JACOBS LEVY EQUITY MANAGEMENT, INC Q2 2018 Filing
Filed August 14, 2018
Portfolio Value
$6.4B
Holdings
1,013
Report Date
Q2 2018
Filing Type
13F-HR
All Holdings (1,013 positions)
| Stock | Value |
|---|---|
—NAVIDEA BIOPHARMACEUTICALS I | $81K |
—EP ENERGY CORP | $78K |
—HC2 HLDGS INC | $75K |
SBSAFE BULKERS INC | $72K |
—BSQUARE CORP | $68K |
—ARSANIS INC | $42K |
SCYXEURSCYNEXIS INC | $35K |
—OBALON THERAPEUTICS INC | $24K |
—PLURISTEM THERAPEUTICS INC | $22K |
—ACTINIUM PHARMACEUTICALS INC | $18K |
—CELLDEX THERAPEUTICS INC NEW | $15K |
—AGILE THERAPEUTICS INC | $15K |
—RADISYS CORP | $14K |
PreviousPage 11 of 11